Recommendations for the diagnosis and treatment of gout in China

VernacularTitle:痛风诊疗规范
Author: Dong XU ¹ ; Xiaoxia ZHU ; Hejian ZOU ; He LIN ; Yan ZHAO
Author Information

1. 中国医学科学院　北京协和医学院　北京协和医院风湿免疫科　国家皮肤与免疫疾病临床医学研究中心　疑难重症及罕见病国家重点实验室　风湿免疫病学教育部重点实验室，北京　100730
Keywords: Gout; Hyperuricemia; Diagnosis; Treatment; Prognosis
From: Chinese Journal of Internal Medicine 2023;62(9):1068-1076
CountryChina
Language:Chinese
Abstract: Gout is a metabolic disease resulting from the accumulation of monosodium urate (MSU) in joints, leading to crystal-induced arthritis. In China, gout is common, but there is insufficient knowledge regarding standardized criteria for the diagnosis and treatment of this condition. Based on evidence and guidelines from China and other countries, the Chinese Rheumatology Association developed standardized criteria for the diagnosis and treatment of gout in China. The purpose was to standardize gout diagnosis methods as well as treatment opportunities and strategies in order to reduce misdiagnosis, missed diagnosis, and irreversible damage.